Abstract Library

#3446 Metabolomic profile of extra-pancreatic NET: A novel prognostic tool?

Introduction: Reprogrammed metabolism is one of the key hallmarks of cancer. Thus, metabolic profiling of cancer patients represents a promising tool. To date, metabolomics remains largely unexplored in NETs.

Conference:

Presenting Author:

Authors: La Salvia A, Soldevilla B, Lens-Pardo A, López-López A, Carretero C,

Keywords: NET, metabolic signaling, molecular pathways, plasma metabolites, prognostic biomarker,

#3271 Comprehensive metabolomic plasma profiling identifies novel potential diagnostic biomarkers in patients with advanced neuroendocrine tumors

Introduction: NETs are heterogeneous neoplasms that have the capacity to secrete hormones or bioactive molecules. Dysregulated metabolism is one of the key hallmarks of cancer and the altered expression of metabolic enzymes is deeply involved in tumor development, progression, and metastasis.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Soldevilla B, Lens-Pardo A, López-López �, Carretero-Puche C, La Salvia A,

Keywords: NETs, metabolic signalling, plasma metabolites, diagnostic biomarker,

#1875 Potential Anti-Tumor Activity of Biguanides and Statins in Neuroendocrine Tumor Cells

Introduction: Recent studies have suggested that biguanides and statins have beneficial effects on various cancer types; however, the precise effects and the molecular mechanisms underlying this pathophysiological association are still not well understood in neuroendocrine tumor (NETs).

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Herrera-Martínez A, Pedraza-Arévalo S, López-López F, Gahete M, Gálvez-Moreno M,

Keywords: NETs,biguanides,statins,